Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $13

Benzinga · 2d ago
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $12 to $13.